Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG34662

ITGA6 Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

The ITGA6 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the near-haploid human HAP1 cell line, engineered to disrupt the ITGA6 gene encoding integrin ??6. Loss of ITGA6 impairs laminin-dependent adhesion and downstream signaling through FAK, Src, PI3K, and Akt, affecting cell migration and survival. This model is ideal for studying integrin-mediated adhesion, cancer biology, and drug target validation. HAP1 cells provide a simplified genomic background for clean genetic screens and knockout studies. The ITGA6 knockout population supports functional assays such as laminin adhesion, migration/invasion, and phospho-FAK analysis, facilitating investigation of pathways linked to epidermolysis bullosa and metastasis.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    ITGA6

    Gene Identifier

    NCBI Gene ID 3655

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The ITGA6 Knockout HAP1 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population designed for loss-of-function studies of the human ITGA6 gene. This product consists of a heterogeneous pool of HAP1 cells carrying disrupted ITGA6 alleles, providing a robust model system to interrogate integrin ??6 function without the need for single-cell clone isolation. The polyclonal format ensures efficient knockout at the population level, minimizing clonal artifacts and enabling reproducible phenotypic analysis in functional genomics applications.

HAP1 is a near-haploid human cell line originally derived from the chronic myeloid leukemia cell line KBM-7. Its haploid karyotype simplifies genetic manipulation and enables high-efficiency CRISPR/Cas9 genome editing, making it an ideal platform for generating knockout models. HAP1 cells retain functional integrin adhesion and signaling pathways, including laminin-dependent adhesion mediated by integrin ??6??1 and ??6??4 heterodimers, providing a physiologically relevant background for studying ITGA6-dependent processes. The near-haploid state also removes diploid allelic variability, ensuring unambiguous genotype-phenotype correlations in loss-of-function studies.

The ITGA6 gene encodes integrin ??6, a transmembrane adhesion receptor that heterodimerizes with integrin ??1 (ITGB1) or ??4 (ITGB4) to bind laminin extracellular matrix proteins. Laminin engagement triggers integrin clustering, leading to activation of focal adhesion kinase (FAK) and Src family kinases, which in turn stimulate downstream PI3K-Akt and MAP kinase pathways. These signaling cascades regulate cytoskeletal reorganization through Rho GTPases, and influence gene expression programs controlling cell migration, survival, and differentiation. In hemidesmosomes, ITGA6/ITGB4 complexes connect laminin to intermediate filaments, maintaining epithelial integrity. Integrin ??6 function is further modulated by growth factors such as TGF-?? and EGF, and transcriptionally regulated by p63 and MYC, integrating external cues with adhesive signaling.

In HAP1 cells, ITGA6 is functionally expressed and mediates adhesion to laminin matrices. CRISPR/Cas9-mediated disruption of ITGA6 in this polyclonal population abrogates laminin-dependent cell attachment and attenuates downstream signaling events, including FAK autophosphorylation at Y397 and Akt activation. This knockout model is particularly valuable for studying cancer cell adhesion and migration, as HAP1 cells recapitulate aspects of leukemic cell behavior. Moreover, the haploid background enables combinatorial gene disruption screens, facilitating identification of synthetic lethal interactions or functional partners in the integrin adhesion network.

Typical applications include integrin-mediated adhesion assays on laminin substrates, real-time cell migration and invasion monitoring, phospho-FAK analysis by western blotting, and flow cytometric quantification of integrin surface expression changes. The polyclonal knockout population is suitable for haploid genetic screens to uncover genes that interact with ITGA6 in focal adhesion dynamics, ECM-receptor interactions, hemidesmosome assembly, and cancer metastasis pathways. In biomedical research, this model supports studies of epidermolysis bullosa with pyloric atresia, congenital nephrotic syndrome, and muscular dystrophy mechanisms, as well as drug target validation and functional genomics approaches. For further inquiries and ordering information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)